NERVOSYL
NERVOSYL
Authorised
- ATROPA BELLA-DONNA C9
- VALERIANA OFFICINALIS D3
- PASSIFLORA INCARNATA D3
- THERIDION CURASSAVICUM C9
- STRYCHNOS IGNATII C9
- MATRICARIA RECUTITA C9
Product identification
Medicine name:
NERVOSYL
Active substance:
- ATROPA BELLA-DONNA C9
- VALERIANA OFFICINALIS D3
- PASSIFLORA INCARNATA D3
- THERIDION CURASSAVICUM C9
- STRYCHNOS IGNATII C9
- MATRICARIA RECUTITA C9
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
ATROPA BELLA-DONNA C90.17/gram(s)1.00millilitre(s)
-
VALERIANA OFFICINALIS D30.17/gram(s)1.00millilitre(s)
-
PASSIFLORA INCARNATA D30.17/gram(s)1.00millilitre(s)
-
THERIDION CURASSAVICUM C90.17/gram(s)1.00millilitre(s)
-
STRYCHNOS IGNATII C90.17/gram(s)1.00millilitre(s)
-
MATRICARIA RECUTITA C90.17/gram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QV03AX
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Homeopathic medicinal products (Article 19 of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boiron
Marketing authorisation date:
Manufacturing sites for batch release:
- Boiron
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/6186456 0/2009
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022
